Reply to Chao Song's Letter to the Editor re: Florus C. de Jong, Iris G. Iflé, Angelique C. van der Made, et al. A Genomic Urine Assay for Surveillance of Patients with Bladder Cancer Treated with Radiotherapy. Eur Urol Open Sci 2024;62:131-9.
作者信息
de Jong Florus C, Zuiverloon Tahlita C M, Boormans Joost L
机构信息
Department of Urology, Erasmus University Medical Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
出版信息
Eur Urol Open Sci. 2024 Jun 19;66:9. doi: 10.1016/j.euros.2024.06.003. eCollection 2024 Aug.
Abstract
摘要
相似文献
1
Reply to Chao Song's Letter to the Editor re: Florus C. de Jong, Iris G. Iflé, Angelique C. van der Made, et al. A Genomic Urine Assay for Surveillance of Patients with Bladder Cancer Treated with Radiotherapy. Eur Urol Open Sci 2024;62:131-9.回复晁松致编辑的信，信的内容是关于弗洛鲁斯·C·德容、艾丽斯·G·伊弗莱、安热利克·C·范德马德等人的《一种用于监测接受放疗的膀胱癌患者的基因组尿液检测方法》。《欧洲泌尿外科开放科学》2024年；62:131 - 9。
Eur Urol Open Sci. 2024 Jun 19;66:9. doi: 10.1016/j.euros.2024.06.003. eCollection 2024 Aug.
2
Re: Florus C. de Jong, Iris G. Iflé, Angelique C. van der Made, et al. A Genomic Urine Assay for Surveillance of Patients with Bladder Cancer Treated with Radiotherapy. Eur Urol Open Sci 2024;62:131-9.回复：弗洛鲁斯·C·德容、艾丽斯·G·伊弗莱、安热利克·C·范德·马德等。一种用于监测接受放射治疗的膀胱癌患者的基因组尿液检测方法。《欧洲泌尿外科开放科学》2024年；62卷：131 - 139页。
Eur Urol Open Sci. 2024 Jun 21;66:10-11. doi: 10.1016/j.euros.2024.04.003. eCollection 2024 Aug.
3
Reply to Eliezer M. Van Allen, Levi A. Garraway and Jonathan E. Rosenberg's Letter to the Editor re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014.回复埃利泽·M·范·艾伦、利瓦伊·A·加拉韦和乔纳森·E·罗森伯格致编辑的信，信的内容涉及弗洛里斯·H·格罗嫩迪克、杰罗恩·德容、伊丽莎白·E·弗兰森·范·德·普特等人的文章：《ERBB2突变特征定义了一组对新辅助化疗有良好反应的肌层浸润性膀胱癌》。《欧洲泌尿外科杂志》即将发表。http://dx.doi.org/10.1016/j.eururo.2015.01.014 。
Eur Urol. 2015 Aug;68(2):e33-4. doi: 10.1016/j.eururo.2015.02.043. Epub 2015 Mar 13.
5
Reply to Massimo Valerio, Mark Emberton, and Hashim U. Ahmed's Letter to the Editor re: Henk G. van der Poel, Roderick C.N. van den Bergh, Erik Briers, et al. Focal Therapy in Primary Localised Prostate Cancer: The European Association of Urology Position in 2018. Eur Urol 2018;74:84-91.回复马西莫·瓦莱里奥、马克·恩伯顿和哈希姆·U·艾哈迈德致编辑的信，信的内容涉及：亨克·G·范德波尔、罗德里克·C·N·范登伯格、埃里克·布里尔斯等人所著的《原发性局限性前列腺癌的聚焦治疗：2018年欧洲泌尿外科学会立场》。《欧洲泌尿外科杂志》2018年；74卷：第84 - 91页。
Eur Urol. 2019 Feb;75(2):e23-e24. doi: 10.1016/j.eururo.2018.08.043. Epub 2018 Sep 17.
6
Reply to Joep J. de Jong and Ewan A. Gibb's Letter to the Editor re: Gottfrid Sjödahl, Johan Abrahamsson, Karin Holmsten, et al. Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes. Eur Urol. 2022;81:316-7. Neoadjuvant Chemotherapy Response in Muscle-invasive Bladder Cancer: Differences in Intrinsic Biology or Subtyping Nomenclature?对乔普·J·德容和伊万·A·吉布致编辑的信的回复，信的主题为：戈特弗里德·舍达尔、约翰·亚伯拉罕松、卡琳·霍尔姆斯特伦等人。尿路上皮癌分子亚型对新辅助化疗的不同反应。《欧洲泌尿外科杂志》。2022年；81卷：316 - 7页。肌层浸润性膀胱癌的新辅助化疗反应：内在生物学差异还是亚型命名差异？
Eur Urol. 2022 Apr;81(4):e92-e93. doi: 10.1016/j.eururo.2021.12.035. Epub 2022 Jan 14.
8
Reply to Pim J. van Leeuwen and Henk G. van der Poel's Letter to the Editor re: Karim A. Touijer, Robert J. Karnes, Niccolo Passoni, et al. Survival Outcomes of Men with Lymph Node-positive Prostate Cancer After Radical Prostatectomy: A Comparative Analysis of Different Postoperative Management Strategies. Eur Urol 2018;73:890-6.对皮姆·J·范·李文和亨克·G·范·德·波尔致编辑的信的回复，信的内容涉及卡里姆·A·图耶尔、罗伯特·J·卡恩斯、尼科洛·帕索尼等人的《根治性前列腺切除术后淋巴结阳性前列腺癌男性的生存结果：不同术后管理策略的比较分析》。《欧洲泌尿外科杂志》2018年；73卷：890 - 896页。
Eur Urol. 2018 Jul;74(1):e18-e19. doi: 10.1016/j.eururo.2018.04.002.
9
Reply to Rodolfo Montironi, Marina Scarpelli, Alessia Cimadamore, and Gregor Mikuz's Letter to the Editor re: Theo van der Kwast, Fredrik Liedberg, Peter C. Black, et al. International Society of Urological Pathology Expert Opinion on Grading of Urothelial Carcinoma. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.03.017. Focus on Our Personal Recollections and Observations.回复鲁道夫·蒙蒂罗尼、玛丽娜·斯卡尔佩利、阿莱西娅·奇马达莫尔和格雷戈尔·米库兹给编辑的信，内容涉及西奥·范德·夸斯特、弗雷德里克·利德伯格、彼得·C·布莱克等人。国际泌尿病理学会关于尿路上皮癌分级的专家意见。《欧洲泌尿外科聚焦》。即将发表。https://doi.org/10.1016/j.euf.2021.03.017。聚焦我们的个人回忆与观察。
Eur Urol Focus. 2022 May;8(3):885-886. doi: 10.1016/j.euf.2021.04.025. Epub 2021 May 12.
10
Reply to Nikolaos Grivas and Henk G. van der Poel's Letter to the Editor re: Rui Farinha, Giuseppe Rosiello, Artur De Oliveira Paludo, et al. Selective Suturing or Sutureless Technique in Robot-assisted Partial Nephrectomy: Results from a Propensity-score Matched Analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.03.019.对尼古拉斯·格里瓦斯（Nikolaos Grivas）和亨克·G·范德波尔（Henk G. van der Poel）致编辑的信的回复：关于鲁伊·法里尼亚（Rui Farinha）、朱塞佩·罗西耶洛（Giuseppe Rosiello）、阿图尔·德·奥利维拉·帕卢多（Artur De Oliveira Paludo）等人的《机器人辅助部分肾切除术中的选择性缝合或无缝合技术：倾向评分匹配分析的结果》。《欧洲泌尿外科聚焦》。即将发表。https://doi.org/10.1016/j.euf.2021.03.019
Eur Urol Focus. 2022 May;8(3):888-889. doi: 10.1016/j.euf.2021.05.001. Epub 2021 May 22.
本文引用的文献
1
Clinical Trial Protocol for "Replace Cysto": Replacing Invasive Cystoscopy with Urine Testing for Non-muscle-invasive Bladder Cancer Surveillance-A Multicenter, Randomized, Phase 2 Healthcare Delivery Trial Comparing Quality of Life During Cancer Surveillance with Xpert Bladder Cancer Monitor or Bladder EpiCheck Urine Testing Versus Frequent Cystoscopy.“替换膀胱镜检查”临床试验方案：用尿液检测取代侵入性膀胱镜检查用于非肌层浸润性膀胱癌监测——一项多中心、随机、2期医疗服务试验，比较使用Xpert膀胱癌监测仪或膀胱上皮细胞检测尿液检测与频繁膀胱镜检查进行癌症监测期间的生活质量。
Eur Urol Open Sci. 2024 Mar 21;63:19-30. doi: 10.1016/j.euros.2024.02.018. eCollection 2024 May.
2
A Genomic Urine Assay for Surveillance of Patients with Bladder Cancer Treated with Radiotherapy.一种用于监测接受放射治疗的膀胱癌患者的基因组尿液检测方法。
Eur Urol Open Sci. 2024 Mar 10;62:131-139. doi: 10.1016/j.euros.2024.02.009. eCollection 2024 Apr.
3
Circulating tumor DNA based minimal residual disease detection and adjuvant treatment decision-making for muscle-invasive bladder cancer guided by modern clinical trials.基于循环肿瘤DNA的肌层浸润性膀胱癌微小残留病检测及现代临床试验指导下的辅助治疗决策
Transl Oncol. 2023 Nov;37:101763. doi: 10.1016/j.tranon.2023.101763. Epub 2023 Aug 30.
4
Circulating and urinary tumour DNA in urothelial carcinoma - upper tract, lower tract and metastatic disease.尿路上皮癌（上尿路、下尿路和转移性疾病）中的循环和尿肿瘤 DNA。
Nat Rev Urol. 2023 Jul;20(7):406-419. doi: 10.1038/s41585-023-00725-2. Epub 2023 Mar 28.
Zotero 插件